Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis
Christoph Gräni(University Hospital of Bern), Raymond Y. Kwong(Broad Institute), Ayaz Aghayev(Brigham and Women's Hospital), Michael Jerosch‐Herold(Brigham and Women's Hospital), Loïc Bière(Brigham and Women's Hospital), Christian Eichhorn(University Hospital of Basel), Venkatesh L. Murthy(Rush University Medical Center), Kyoichi Kaneko(Brigham and Women's Hospital), Ron Blankstein(Brigham and Women's Hospital), Vikram Agarwal(Brigham and Women's Hospital), Michael L. Steigner(Brigham and Women's Hospital)
Cited by 118
Related Papers
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
|New England Journal of Medicine|2010|706
Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis
|Journal of the American College of Cardiology|2017|426
SCCT 2021 Expert Consensus Document on Coronary Computed Tomographic Angiography: A Report of the Society of Cardiovascular Computed Tomography
|Journal of cardiovascular computed tomography|2020|368
CAD-RADS™ 2.0 - 2022 Coronary Artery Disease-Reporting and Data System
|Journal of cardiovascular computed tomography|2022|365